Takefumi Ishii

1.2k citations
20 papers · 962 indexed · h-index 15
Topics
Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers)Eosinophilic Disorders and Syndromes (8 papers)Chronic Myeloid Leukemia Treatments (8 papers)

In The Last Decade

Takefumi Ishii

20 papers receiving 943 citations

Peers

Takefumi Ishii
Comparison fields: 5 of 62
  • Hematology 556
  • Genetics 523
  • Molecular Biology 390
  • Rheumatology 217
  • Immunology 211
Replace Sandra Moore with:
Sandra Moore United States
Amy J. Zigler United States
Gabriele Gugliotta Italy
Jennifer Adelsperger United States
Antony C. Cambareri Australia
Irina Sadovnik Austria
Hui Hao-Shen Switzerland
Claudiu Cotta United States
Juliana Schwaab Germany
Daniel Santos United States
Takefumi Ishii relative to Sandra Moore United States Sandra Moore's profile →
Citations per field
00.5×1.5×
Sandra Moore · 1×
Citations per year

Countries citing papers authored by Takefumi Ishii

Since Specialization
Citations

This map shows the geographic impact of Takefumi Ishii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takefumi Ishii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takefumi Ishii more than expected).

Fields of papers citing papers by Takefumi Ishii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takefumi Ishii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takefumi Ishii. The network helps show where Takefumi Ishii may publish in the future.

Co-authorship network of co-authors of Takefumi Ishii

This figure shows the co-authorship network connecting the top 25 collaborators of Takefumi Ishii. A scholar is included among the top collaborators of Takefumi Ishii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takefumi Ishii. Takefumi Ishii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 67
3 30
4 26
5 20
6 3
7 1
8 11
9 33
10 49
11 159
12 2
13 100
14 106
15 134
16 18
17 100
18 15
19 36
20 51

About Takefumi Ishii

Takefumi Ishii is a scholar working on Genetics, Hematology and Rheumatology, having authored 20 papers that have together received 962 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Eosinophilic Disorders and Syndromes (8 papers) and Chronic Myeloid Leukemia Treatments (8 papers). The work is most often cited by research in Hematology (556 citations), Genetics (523 citations) and Rheumatology (217 citations). Takefumi Ishii has collaborated with scholars based in United States, Japan and Türkiye. Frequent co-authors include Mingjiang Xu, Ronald Hoffman, E Bruno, Yasuhiro Ebihara, Tatsutoshi Nakahata, Kohichiro Tsuji, Yan Zhao, Shigetaka Asano, Wen‐Yang Hu and Ryuhei Tanaka. Their work appears in journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026